Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 5, 2026

Back to the front page

From X

@StableBread

Fajasy on X

The patents behind the key-capture technique of Nubeva Technologies $NBVAF (TSXV: $NBVA) now belong to Netskope $NTSK, a ~$7.6B cloud security company. In March 2024, Nubeva sold its web-traffic (TLS) technology for $1M to an unnamed “mid-sized U.S. based cyber security company,” keeping the right to support the product’s one remaining customer (still 41% of FY2026 revenue). USPTO records show Nubeva assigning five patents to Netskope in one filing signed March 1, 2024, three days before the sale closed, and recorded March 19, 2024. Three are cloud-security patents from Nubeva’s first business. The other two cover key extraction: 1) U.S. 11,805,107: The patent behind Session Key Intercept (SKI), Nubeva’s TLS key-copying software, granted October 31, 2023 to co-founders Greig Bannister and Randy Chou. It covers software that pulls an encryption key out of a computer’s memory and forwards it to whatever needs to decrypt. 2) U.S. 11,494,484: Granted November 8, 2022, and announced by Nubeva as its “U.S. Patent for Ransomware Decryption Technology,” with Bannister saying it “underpins Nubeva’s ability to continue as an effective solution against ransomware.” Bannister, the co-inventor on every SKI patent, resigned as CTO and director on March 1, 2024, the same day the patent assignment was signed, and went to Netskope with the patents. Following the TLS sale, Nubeva kept the other half of the process, turning captured keys into a working decryptor. It filed two patents on the decryptor side in 2024, both since granted: 1) U.S. 12,430,438, granted September 30, 2025: It covers running the ransomware in a sandbox (an isolated test machine) against a known file and matching the result to a library of standard encryption methods to find the one the malware used. With the method and the captured key, Nubeva can build the decryptor. 2) U.S. 12,561,431, granted February 24, 2026: It covers ransomware that encrypts scattered pieces of a large data store, like a virtual machine’s disk, from several processors at once. Nubeva’s method maps which pieces were encrypted, then decrypts each piece with the captured keys. When granting the second patent, the patent examiner flagged PayBreak, a 2017 Boston University research system that also copied ransomware’s keys as it ran, as earlier work in the same area. Copying ransomware’s keys mid-attack wasn’t new by 2024. Nubeva’s patents protect the recovery built on top of the captured keys. NuRR, Nubeva’s ransomware product, copies keys the same way SKI does, but Netskope now owns the two key-capture patents. Nubeva hasn’t disclosed any license from Netskope that lets NuRR keep using the patents. Any buyer would want the license question answered first. Chou has said Nubeva needs four AI patents granted before it partners or sells, and two are still pending. In a July 2024 video, he said a buyer wants the patents issued, since “if you are patent pending there’s a significant discount on the technology itself.” The last two are now well past the early-2026 timing he called typical, with no new date from Chou.
@SouthernValue95

SouthernValue on X

$SKYD should probably be a ~$4 stock. Unlike $PARA and $WBD it cannot breakup/sell - the only way out is through. Thats no easy road: starting almost 7x levered and needs to achieve MSD growth and to find $6B synergies from two companies that have already been thoroughly gutted to hit their deleveraging plan. Interest expense 150% of FCF. Rates exploding higher so they better hope they can de-lever. Potential seismic changes to entertainment in next 3-5yrs from generative content and short-form competition are existential threats. With any decline in revenue $SKYD will not be able to afford its sports rights renewals and the entire legacy business falls apart from there. Putting ~30% odds $NFLX gets another shot at WB studio in eventual bankruptcy. If you disagree and you are optimistic, please share why? I'm openminded but do not currently see it. Mgmt seems shell-shocked in Faber interview this AM getting a few tough questions. https://t.co/RKBucH3xlT

Investor Letters

All letters

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

MDA $4.2B
Aurelion Research 4 clicks

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

CURB $3.6B
Real Assets, Real Value 5 clicks

Stevanato down 30%. Yikes.

Stevanato fell 30% after forecasting low-single-digit 2027 growth as lower Nexa syringe volumes from a GLP-1 customer offset solid Q3…

STVN $3.6B
Best Anchor Stocks 3 clicks
CHWY · long

Chewy INC

Chewy (CHWY) is presented as a long opportunity after a prior 2022 short thesis played out.

CHWY $9.2B
Value Investors Club 5 clicks

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet…

ABR $2.2B
John Hempton's Newsletter 4 clicks

TSOH Weekly Roundup (10/30/2026)

Markel spent $315 million repurchasing shares in Q3 as Thrive agreed to buy ADT for $7.6 billion and Hasbro cited rising adult toy demand.

ADT $7.2B
TSOH Investment Research 1 click

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 277

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.